Who operates Eviora MD?

The site does not say. There is an info@evioramd.com address and no phone number, no street address, no named operating company or principal, and no LegitScript reference. Its own disclaimer identifies "Eviora MD" as a platform facilitating access to independent providers and compounding pharmacies, none of which is named either. This is the least identifiable service here — its two sister brands publish at least a phone number, and New Wave Health publishes a full street address.

What does Eviora MD cost?

It publishes "from $149/mo" and nothing else. The semaglutide, tirzepatide and microdose treatment pages carry no price, there is no plan table, and nothing states what the figure covers, whether it holds as your dose rises, or what commitment earns it. Its peptide catalog is fully priced, which makes the absence on the GLP-1 side look like a choice rather than an oversight. If a published price matters, Idgie Health, No BS RX, Prime Doctor RX, Edessa and Rx.com all table theirs.

Is Eviora MD's NAD⁺ competitively priced?

Not against its own sister brand. Eviora sells NAD⁺ injection at $199/month; RX Bella sells the identical SKU, described in identical words inside an identical catalog, at $159. That is a $40 monthly difference — about $480 a year — for what the sites themselves present as the same product. New Wave Health also charges $199. If you are buying NAD⁺ from this cluster, RX Bella is the cheaper door.

Is the peptide catalog Eviora MD's own?

No. RX Bella and New Wave Health publish the same menu — the same SKUs at the same prices, the same per-product sentences, the same six numbered focus areas and the same "Precision peptides, guided by your goal" hero. All three run the same disclaimer boilerplate with the brand name swapped. They are separate businesses with separate reviews, but a reader comparing them on peptides is comparing three front doors to one catalog.

Eviora MD is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: "Programs from $149/mo" is the only figure published; no plan table, no address, phone or state list. It is cash-pay and states it does not bill insurance. What our record does not establish: which states it serves. Ask for those in writing before you pay.

Is Eviora MD expensive compared with other GLP-1 telehealth providers?

Eviora MD publishes a starting figure of $149/mo. Across the 52 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $269 with a median of $179, which puts Eviora MD below the median, toward the cheaper end. The other 31 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Updated September 2026

Eviora MD review

Least identifiable here

A polished storefront over a borrowed catalog, with no company, address, pharmacy or state list behind it.

Our verdict

Eviora MD presents well and discloses almost nothing. The clinical copy is correct — the compounded-medication disclaimer is properly worded, and the trajectory chart is sourced to STEP and SURMOUNT-1 and labeled as trial averages rather than a promise. But a reader trying to work out who they'd be buying from finds an email address and nothing else: no phone, no street address, no named company, no pharmacy, and an About page whose "STATES SERVED" heading renders with no number under it. Its single GLP-1 figure, "from $149/mo," has no plan table behind it. And its peptide catalog isn't distinctively its own — on NAD⁺ it's $40 more expensive than the same SKU next door.

Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; a commission never changes what we write about a provider. How we make money.

Check availability →"Programs from $149/mo" is the only figure published; no plan table, no address, phone or state list

At a glance

Category: GLP-1 telehealth
Access: "Programs from $149/mo" is the only figure published; no plan table, no address, phone or state list
Medications: Compounded semaglutide · Compounded tirzepatide
Insurance: Cash-pay, no insurance
Visit: Quiz intake / Async intake
Availability: Not published
Updated: September 2026

What it is

A self-described concierge telehealth platform selling compounded GLP-1 weight-loss care, a lower-dose microdose program, NAD⁺ and a six-focus-area peptide menu. It states it facilitates access to independent US board-certified providers and state-licensed compounding pharmacies and does not practice medicine, prescribe or dispense. Beyond the brand name and an info@ email address, it identifies no company, principal, address or phone number anywhere on the site.

How it works

Asynchronous, via an online eligibility check and consultation, with structured check-ins and secure messaging described. Medication is "prepared by partner compounding pharmacies in the United States," never named. ⚠ No footprint is published at all: the About page includes a "STATES SERVED" heading with nothing beneath it, and no page enumerates a state list. ⚠ Its peptide and NAD⁺ catalog is shared verbatim with RX Bella and New Wave Health — the same SKUs at the same prices with the same per-product descriptions and the same six numbered focus areas — with NAD⁺ injection the only price that varies across the three.

Pricing transparency

One figure, no table. "GLP-1 weight loss programs from $149/mo" runs in the announcement bar and hero, and "Plans from $149/mo · confirmed after provider review" appears under the BMI tool; the semaglutide, tirzepatide and microdose treatment pages carry no price at all. Nothing states what the figure includes, whether it survives dose escalation, or what commitment it requires. The peptide side is fully priced from the shared catalog: BPC-157 acetate $199/mo, BPC-157 $250, sermorelin $249, epithalon $249, GHK-Cu $249, PT-141 $249, MOTS-C $279, tesamorelin $299, thymosin alpha-1 $299, semax/selank $299, GHK-Cu/epithalon $319, CJC-1295/ipamorelin $329, blends to $379, NAD⁺ injection $199. ⚠ That NAD⁺ line is $159 on RX Bella for the identical product described in identical words.

Branded vs compounded

Compounded semaglutide and tirzepatide, a GLP-1 microdose program, injectable NAD⁺, and the shared nineteen-SKU peptide menu. ⚠ Like RX Bella and unlike New Wave Health, it files BPC-157/GHK-Cu/KPV/TB500 and BPC-157/TB-500/GHK-Cu under "Anti-Aging & Growth Hormone" and describes them as "a copper peptide," which describes one ingredient of a blend that is neither primarily copper nor a growth-hormone product. On the evidence: the GLP-1 outcome data belongs to the branded products, not compounded copies; injectable NAD⁺ and the growth-hormone secretagogues are compounded, not FDA-approved, and have no controlled human outcome trials for the uses they are marketed on.

Pros and watch-outs

What we like

Compounded-medication disclaimer correctly worded and prominent
Cites STEP (NEJM 2021) and SURMOUNT-1 (NEJM 2022) properly and labels its chart as trial averages
Peptide and NAD⁺ menu fully priced, unlike its GLP-1 line
States plainly that eligibility is determined only after provider evaluation

Watch-outs

No operating company, street address, phone number or principal named anywhere — an email address is the only contact
"STATES SERVED" heading on the About page renders with no figure beneath it
One GLP-1 price published and no plan table; treatment pages carry no price at all
NAD⁺ is $199 for the identical SKU RX Bella sells at $159
Peptide catalog, prices and descriptions identical to two other brands; blends filed under the wrong category
Dispensing pharmacy never named; no LegitScript certification referenced

Best for

Readers set on this shared catalog who do not need the operator, the pharmacy or the state list identified.

Who should look elsewhere

Anyone who wants to know which company they are buying from, or who is comparing this cluster on NAD⁺ price.

The evidence behind what Eviora MD prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
Tirzepatide vs semaglutide for weight loss: what the trials actually support
Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.
NAD injections: how to get them near you or online, and what the evidence really says
Subcutaneous NAD+ injections are sold as a cheaper, at-home alternative to the IV drip — via “near me” clinics or telehealth shipped to your door. They’re compounded, not FDA-approved, and have no outcome trials; oral NR/NMN precursors are the route with the human data.
Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
BPC 157: what the evidence actually shows (and what it doesn't)
The 'healing peptide' has a deep rodent literature and almost no human data. A straight read of where the science stands.
MOTS-c: real mitochondrial biology, absent human evidence
A genuine mitochondrial-derived peptide with interesting rodent data on metabolism and exercise — but no human outcome trials. Promising biology, not a proven therapeutic.
PT-141 (bremelanotide): the evidence on a peptide that is actually FDA-approved
Bremelanotide (Vyleesi) is FDA-approved for HSDD in premenopausal women, with phase-3 trial evidence. A straight read of what's proven — and where off-label use goes beyond it.

How Eviora MD compares

A few alternatives worth a look, depending on what you’re optimizing for.

RX Bella
Readers who want GLP-1, NAD⁺ and peptides from one brand and will price it from the catalog, not the banner
See RX Bella →
New Wave Health
Buyers who want a named local operator and an honest statement of which states it serves
See New Wave Health →
Idgie Health
One menu covering GLP-1, NAD⁺, sermorelin and hair care with the pharmacy named
See Idgie Health →

Compare all providers side by side →

More GLP-1 telehealth reviews: Oak LongevityCareBareRXSnagRxHe & She MDHumeCare+Try Ageless

Nadia Feldman

Access & cost · Reviewed and last verified September 2026

How we assessed this. This review reflects Aminoscope’s own read of Eviora MD’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.

Frequently asked

Who operates Eviora MD?: The site does not say. There is an info@evioramd.com address and no phone number, no street address, no named operating company or principal, and no LegitScript reference. Its own disclaimer identifies "Eviora MD" as a platform facilitating access to independent providers and compounding pharmacies, none of which is named either. This is the least identifiable service here — its two sister brands publish at least a phone number, and New Wave Health publishes a full street address.
What does Eviora MD cost?: It publishes "from $149/mo" and nothing else. The semaglutide, tirzepatide and microdose treatment pages carry no price, there is no plan table, and nothing states what the figure covers, whether it holds as your dose rises, or what commitment earns it. Its peptide catalog is fully priced, which makes the absence on the GLP-1 side look like a choice rather than an oversight. If a published price matters, Idgie Health, No BS RX, Prime Doctor RX, Edessa and Rx.com all table theirs.
Is Eviora MD's NAD⁺ competitively priced?: Not against its own sister brand. Eviora sells NAD⁺ injection at $199/month; RX Bella sells the identical SKU, described in identical words inside an identical catalog, at $159. That is a $40 monthly difference — about $480 a year — for what the sites themselves present as the same product. New Wave Health also charges $199. If you are buying NAD⁺ from this cluster, RX Bella is the cheaper door.
Is the peptide catalog Eviora MD's own?: No. RX Bella and New Wave Health publish the same menu — the same SKUs at the same prices, the same per-product sentences, the same six numbered focus areas and the same "Precision peptides, guided by your goal" hero. All three run the same disclaimer boilerplate with the brand name swapped. They are separate businesses with separate reviews, but a reader comparing them on peptides is comparing three front doors to one catalog.
Is Eviora MD legit?: Eviora MD is a GLP-1 telehealth service you reach through an online questionnaire and an online intake a clinician reviews. The medications it names are Compounded semaglutide and Compounded tirzepatide. What it publishes up front: "Programs from $149/mo" is the only figure published; no plan table, no address, phone or state list. It is cash-pay and states it does not bill insurance. What our record does not establish: which states it serves. Ask for those in writing before you pay.
Is Eviora MD expensive compared with other GLP-1 telehealth providers?: Eviora MD publishes a starting figure of $149/mo. Across the 52 GLP-1 telehealth providers we review that publish a single monthly figure, those run $49 to $269 with a median of $179, which puts Eviora MD below the median, toward the cheaper end. The other 31 GLP-1 telehealth providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Check availability →

Or compare every GLP-1 provider.